- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
Janssen Submits Additional Marketing Applications for ZYTIGA® In the U.S. and European Union
Simultaneous Submissions Based on Data from Pre-chemo Prostate Cancer Study
Positive Results from First Human Clinical Trials of a First-Generation Artificial Pancreas System is Significant Step Forward for Millions with Type 1 Diabetes
System in Development from Animas-JDRF Partnership Successfully Detects Highs and Lows, and Shown to Safely and Automatically Adjust Insulin Delivery in Clinical Setting
Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add-On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies
Canagliflozin Provides Greater Reduction of A1C Levels in Adults with Type 2 Diabetes in 52-Week Head-to-Head Studies Compared to Sitagliptin and Glimepiride
New STELARA® Five-Year Data Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis
Findings from the Only Psoriasis Clinical Development Program for a Biologic Following Patients Continuously for Five Years Provide Insights on STELARA Long-Term Response and Safety Profile
New Phase 3 Data Show STELARA® Significantly Reduced Signs And Symptoms Of Active Psoriatic Arthritis
Treatment with STELARA Also Resulted in Significant Improvements in Physical Function, Enthesitis and Dactylitis, and Plaque Psoriasis
New Phase 3 Data Show SIMPONI® Intravenous Formulation Significantly Improved Rheumatoid Arthritis Signs And Symptoms In Patients With Active Disease
Study Findings Include Results of SIMPONI Intravenous Formulation on Rheumatoid Arthritis Associated Fatigue
ZYTIGA® Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Phase 3 Results Show Significant Improvement in Radiographic Progression-Free Survival and a Trend for Increased Overall Survival in Patients Receiving ZYTIGA Plus Prednisone